Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease
Dhanshree Jha, Erik N.T.P. Bakker, Rahul Kumar
Journal of Neurochemistry (2023)
Open Access | Times Cited: 23

Showing 23 citing articles:

Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
David Harrison, Andy Billinton, Mark G. Bock, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14897-14911
Closed Access | Times Cited: 27
Microglial NLRP3 Inflammasomes in Alzheimer’s Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics
Gunel Ayyubova, Leelavathi N. Madhu
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
Diana Boraschi, Paola Italiani, Paola Migliorini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
Qiu-Qin Han, Wenhui Li, Peiqing Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 1890-1898
Open Access | Times Cited: 11
Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease
H YAN, Wei Wang, Tingting Cui, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 287-304
Open Access | Times Cited: 4
Therapeutic Potential of TPT-260 in Ischemic Stroke: An Investigation Into Its Anti-Inflammatory Effects and Impact on Microglial Activation
Jun Qian, Xiaoming Guo, Xu Qian, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3055-3066
Open Access
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Wen Xu, Yi Huang, Rongbin Zhou
Cellular and Molecular Immunology (2025)
Open Access
Interleukin 18 and the brain: neuronal functions, neuronal survival and psycho-neuro-immunology during stress
Silvia Alboni, Fabio Tascedda, Akihito Uezato, et al.
Molecular Psychiatry (2025)
Closed Access
Trem2 deficiency attenuates microglial phagocytosis and autophagic‐lysosomal activation in white matter hypoperfusion
Xiao‐Wei Pang, Yun‐Hui Chu, Luo‐Qi Zhou, et al.
Journal of Neurochemistry (2023) Vol. 167, Iss. 4, pp. 489-504
Closed Access | Times Cited: 9
Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer’s Disease
Éva Kiss, Stefan Kins, Karin Gorgas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4165-4165
Open Access | Times Cited: 3
Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer’s disease
Tanmoy Tantra, Abdul Rahaman T A, Nandini Nandini, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107912-107912
Closed Access | Times Cited: 3
Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis
Yixian Li, Peng Yang, Ran Meng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1380-1399
Open Access | Times Cited: 7
Chlamydia pneumoniae in Alzheimer's disease pathology
Lalita Subedi, Bhakta Prasad Gaire, Yosef Koronyo, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
The role of NLRP3 inflammasome-mediated neuroinflammation in chronic noise-induced impairment of learning and memory ability
Yixian Ren, Kangyong Wu, Yongke He, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 286, pp. 117183-117183
Open Access | Times Cited: 2
The deficient CLEC5A ameliorates the behavioral and pathological deficits via the microglial Aβ clearance in Alzheimer’s disease mouse model
Yu-Yi Lin, Wen‐Han Chang, Shie‐Liang Hsieh, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Unraveling Alzheimer’s disease: insights from single-cell sequencing and spatial transcriptomic
Yibo He, Wenqiang Lu, Xiao Zhou, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
Ashley Wagner, Marcus Pehar, Zhimin Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Potential molecular pathways of angiotensin receptor blockers in the brain toward cognitive improvement in dementia
Varnita Karmakar, Bapi Gorain
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103850-103850
Closed Access | Times Cited: 3
SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases
Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, et al.
Prospects in Pharmaceutical Sciences (2024) Vol. 22, Iss. 1, pp. 16-22
Open Access
Preface to the special issue “Neuroimmunology”
Jonathan P. Godbout
Journal of Neurochemistry (2024)
Open Access
Protective effect of walnut active peptide against dextran sulfate sodium-induced colitis in mice based on untargeted metabolomics
Yuan Qi, Xuehang Wang, Yiming Chen, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112998-112998
Closed Access
Differential Expression of Neurodegeneration-Related Genes in SH-SY5Y Neuroblastoma Cells Under the Influence of Cyclophilin A: Could the Enzyme be a Likely Trigger and Therapeutic Target for Alzheimer’s Disease?
Somayeh Pashaei, Sasan Shabani, Soheila Mohammadi, et al.
Neurochemical Research (2024) Vol. 50, Iss. 1
Closed Access
Computational screening of coumarin derivatives as inhibitors of the NACHT domain of NLRP3 inflammasome for the treatment of Alzheimer’s disease
Powsali Ghosh, Ravi Singh, Chayanika Chatterjee, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-17
Closed Access | Times Cited: 1
Page 1

Scroll to top